News Immatics Presents IMA203CD8 PRAME Cell Therapy Data from Ongoing Dose Escalation and Shows Promising Initial Anti-tumor Activity in PRAME-Positive Tumors at ESMO-IO 2025 Congress by Trophic 11 December, 2025
News Immatics Announces Third Quarter 2025 Financial Results and Business Update by Trophic 17 November, 2025
